Targovax ASA: Invitation to second quarter and first half year 2018 results presentation Thursday 23 August
Oslo, Norway, 15 August 2018 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard to treat solid tumors, will announce its second quarter and first half year 2018 results on Thursday, 23 August 2018. A presentation by Targovax's management to investors, analysts and the press will take place in Oslo at 10:00 CET.The results report and the presentation will be available at www.targovax.com in the Investors section from 07:00 CET. Presentation The presentation will take place at 10:00 CET at: Hotel ContinentalStortingsgaten